Suraksha Diagnostic Limited IPO Review
Neutral441-441 · Mainboard
✦
Analyst Verdict
Suraksha Diagnostic Limited IPO
Neutral
IPO at a Glance
Price Band
441-441
Issue Size
846cr
Min. Investment
₹14,994
Opens
2024-11-27
Closes
2024-12-01
Listing
2024-12-04
Category
Mainboard
Key Strengths
✓Leading presence in eastern India’s diagnostic market with growth potential in a fragmented industry.
✓Provides comprehensive diagnostics, including pathology, radiology, and consultations.
✓Equipped with advanced clinical infrastructure and skilled personnel for reliable services.
✓Recognized brand with a focus on quality, supporting individual consumer business.
Key Risks
⚠The company’s business relies heavily on West Bengal, and any loss of business in this region may negatively impact overall performance.
⚠Keeping up with new tests and technology is essential; falling behind could weaken the company’s competitive edge.
⚠The company depends on third-party vendors for testing equipment, and supply disruptions could affect operations.
⚠Franchisees run many collection centres, and failing to meet the required standards could impact quality and reputation.
⚠The diagnostics industry is highly competitive, which could lead to price cuts that affect profits.
⚠The company has significant debt and financial agreements that may reduce flexibility and affect financial health.
Frequently Asked Questions
Should I apply for Suraksha Diagnostic Limited IPO?
Based on our analysis, our rating for Suraksha Diagnostic Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Suraksha Diagnostic Limited IPO?
The company’s business relies heavily on West Bengal, and any loss of business in this region may negatively impact overall performance. Keeping up with new tests and technology is essential; falling behind could weaken the company’s competitive edge. The company depends on third-party vendors for testing equipment, and supply disruptions could affect operations.
What are the strengths of Suraksha Diagnostic Limited IPO?
Leading presence in eastern India’s diagnostic market with growth potential in a fragmented industry. Provides comprehensive diagnostics, including pathology, radiology, and consultations. Equipped with advanced clinical infrastructure and skilled personnel for reliable services.
What is the price band of Suraksha Diagnostic Limited IPO?
The price band for Suraksha Diagnostic Limited IPO is 441-441. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more